Antibodies for Stroke Research

Ace Therapeutics offers thousands of validated monoclonal/polyclonal antibodies and conjugates for your stroke research that can help you deeply study the pathological process of stroke, damage and repair mechanisms of the nervous system, etc. These research tools have been widely used in a variety of analysis pathways, including WB, IHC, FC, ICC, IF, IP, etc. Thanks to our antibody products, you can accurately detect and locate stroke-related molecules, cells, and tissues, and understand their role and regulatory mechanism in the pathogenesis of stroke, providing a scientific basis for the prevention and treatment of stroke.

Related Products

Neuroinflammation

Neuroinflammation

VCAM

TNF/TnfR

TLR2/4

MCP-1

NF-κB

ICAM1/CD54

CCLX

HMGB1

NLRP3

BBB Damage

BBB Damage

MAPK

Wnt-5a

VEGF

NLRP1/3

MMP

Sirt3

S1PRS

AMPK

Neuronal Damage and Repair

Neuronal Damage and Repair

NMDA

PI3KI

nNos

PSD95

Vimenti

NT-4

NGF

BDNF

GDNF

FGF

IGF

MAP 2

TRPCN

GABA

Serotonin & 5HT

Glutamate

Glvcine

Tryptop

Neurop

Substa

CGRP

Dopami

DAPK1

PTEN

Adrenal

Somato

Relaxin

Corista

lon Channels

Oxidative Stress

Oxidative Stress

Nrf2

CK2

GPx

Glutathione Reductase

NOXINOX4

SOD

HO-1

HIF-1

Vascular Mechanisms

Vascular Mechanisms

Thrombin

Integrins

PAI-1

APC

Clotting Factor

P-selection

TXA2

tPA

FXa

Plasminogen

Cell Death and Apoptosis

Cell Death and Apoptosis

NF-κ

Beclin1/Bcl2

Caspase

PI3KI

Akt

mTOR

NARF

cvtochr

Notch1

RIPK1/

P53

RIPK1/3

Fash

MAPK

AMPK

ULK1/ULK2

HIF-1

NICD

Search Under Antibodies

Antibodies for Stroke Research

References
  1. Qin C, Yang S, Chu YH, et al. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022, 7(1):215.
  2. Sierra C, Coca A, Schiffrin EL. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep. 2011,13(3):200-7.
  3. Liu J, Wang Y, Akamatsu Y, et al. Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials. Prog Neurobiol. 2014, 115:138-56.
  4. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 200, 7:97.
  5. Shen Z, Xiang M, Chen C, et al. Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke. Biomed Pharmacother. 2022, 151:113125.
  6. Guan R, Zou W, Dai X, et al. Mitophagy, a potential therapeutic target for stroke. J Biomed Sci. 2018, 25(1):87.
  7. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020, 21(20):7609
  8. Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008, 112(9):3555-62.
  9. Yang C, Hawkins KE, Doré S, et al. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019, 316(2):C135-C153.
All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
0
Inquiry Basket